Palo Alto, United States
Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in investing in outstanding product-focused healthcare companies. Our areas of expertise include small molecule and protein therapeutics; medical devices; diagnostics; and technologies that facilitate drug discovery and life science research.
49
Total Investments
27
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Funding Stage
Series A +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Skyline Ventures
Recent Investments (49)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Sep 2022 | |
| Post-IPO Debt | •••••• | Mar 2017 | |
| Venture Round - SI | •••••• | Jun 2016 | |
| Venture Round - SI | •••••• | May 2015 | |
| Private Equity Round | •••••• | Mar 2015 | |
•••• ••••
|
Series D | •••••• | May 2014 |
|
•••• ••••
|
Venture Round - SI | •••••• | Apr 2014 |
|
•••• ••••
|
Series D | •••••• | Dec 2013 |
|
•••• ••••
|
Series C | •••••• | Jul 2013 |
|
•••• ••••
|
Series D | •••••• | Jan 2013 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
